PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : A8 Touchcare Nano (real-time continuous glucose monitoring) - Type II Diabetes (Children and Young People)

PAD Profile : A8 Touchcare Nano (real-time continuous glucose monitoring) - Type II Diabetes (Children and Young People)

Keywords :
CGM, rtCGM, Continuous glucose monitoring, Medtrum
Brand Names Include :
A8 Touchcare Nano

Traffic Light Status

Status 1 of 1.

Status :
Non Formulary
Formulations :
  • Device
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
NICE
Comments :
No comments returned.
Documents :
Type
Document
Review Date
Guidelines (Local)
CGM Flow chart for Children and Young People with Type II Diabetes -Sept 23.pdf
Evidence Review
CGM choices for CYP with Type II diabetes -September 2023
Evidence Review
CGM in children and Young People with Type II Diabetes -briefing paper - September 2023
Information
CGM in children and young people with Type II Diabetes -Summary comparison table -September 2023

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
06 September 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed that real time Continuous Glucose Monitoring (rtCGM) or intermittently scanned Continuous Glucose Monitoring (isCGM) is offered to children and young people with type II diabetes in line NG18 Diabetes (type 1 and type 2) in children and young people: diagnosis and management).

However a NON-FORMULARY traffic light status  has been agreed for the following device.

A8 Touch Care Nano

  • Has accuracy concerns
  • There is no publicly available data in children
  • Requires calibration


Please see flow charts for guidance on treatment choices.
 

Associated BNF Codes

06. Endocrine System
06.01.06. Diabetic diagnostic and monitoring agents
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More